The future research agenda. A view from the pharmaceutical industry.
As a responsible partner in healthcare systems, the pharmaceutical industry hopes to see a research agenda on pharmaceutical issues that will provide more information on trends in healthcare reform affecting medicines. Urgent questions include whether some forms of cost containment are harming innovation and the quality of care, and what constructive alternatives to policies such as reference pricing can the industry offer?
Barr
C
C
International Pharmaceuticals Group, Pfizer Inc, New York, USA.
D016527:Drug Costs / Q000331:legislation & jurisprudence / Q000639:trends; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D005060:Europe; D018166:Health Care Reform / Q000331:legislation & jurisprudence / Q000639:trends; D006291:Health Policy / Q000331:legislation & jurisprudence / Q000639:trends; D012106:Research; D014481:United States